Therefore, we believe that therapeutic strategies focusing on increased IDE expression and insulin clearance could be helpful in the prevention and/or treatment of T2D, especially when hyperinsulinemia precedes the development of this pathology. The gene discussed is INS; the disease is hyperinsulinism.